Why is Entero Healthcar falling/rising?

As of 28-Aug, Entero Healthcare Solutions Ltd is experiencing a decline in its stock price, currently at 1,199.40, reflecting a decrease of 9.15 points or 0.76%. The stock has been on a downward trend, having lost 5.79% over the last six days, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite outperforming its sector by 0.98% today, the stock has underperformed the benchmark, with a 1-week return of -2.76% compared to the Sensex's -2.34%, and a 1-month return of -4.32% against the benchmark's -1.00%. The company has demonstrated healthy long-term growth, with net sales increasing at an annual rate of 30.10% and a significant operating profit growth of 127.38%. However, the stock's recent performance has been hindered by consistent underperformance against the benchmark over the last three years, generating -8.72% returns in the past year.
In the broader market context, Entero's recent struggles are evident as it has consistently underperformed the BSE500 across multiple time frames, including a notable decline of 15.06% year-to-date while the benchmark has gained 2.48%. The stock's liquidity appears adequate, with a delivery volume increase of 155.65% against the 5-day average, indicating rising investor participation. However, the overall sentiment remains cautious due to the stock's historical underperformance and the fact that it has not capitalized on its strong fundamentals, such as a low debt-to-equity ratio and high institutional holdings at 27.39%. This combination of factors contributes to the stock's current downward trajectory.